BIOMAT Database Logo BIOMAT Database Logo

Growth hormone levels in acromegaly after external radiotherapy. 1977

E F Grayzel

A 56-year-old acromegalic patient was treated with conventional radiotherapy. One year after treatment, the patient's growth hormone level was normal and remained so for a full year. Subsequently, the growth hormone level returned to the pretreatment, acromegalic range. The attainment of a normal growth hormone level after treatment of acromegaly is no assurance that the level will remain normal. Repeated growth hormone level determinations are necessary before cure can be considered permanent.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E F Grayzel
Growth hormone pulsatility in acromegaly following radiotherapy.
June 1999, Pituitary,
E F Grayzel
Acromegaly with 'normal' growth hormone levels.
January 1985, The Western journal of medicine,
E F Grayzel
Normal growth hormone secretion is rare after microsurgical normalization of growth hormone levels in acromegaly.
January 1982, Acta medica Scandinavica,
E F Grayzel
Changes in plasma growth hormone levels after surgical treatment of acromegaly.
March 1970, Proceedings of the Royal Society of Medicine,
E F Grayzel
Acromegaly with normal basal growth hormone levels.
August 1997, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
E F Grayzel
Galanin decreases circulating growth hormone levels in acromegaly.
June 1992, The Journal of clinical endocrinology and metabolism,
E F Grayzel
Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly.
August 2018, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
E F Grayzel
Increased serum growth hormone levels in absence of acromegaly.
April 1977, British medical journal,
E F Grayzel
[Plasma levels of growth hormone and insulin in acromegaly].
January 1966, Annales d'endocrinologie,
E F Grayzel
Plasma-growth-hormone levels in untreated acromegaly and after radioactive implants into the pituitary.
September 1965, Lancet (London, England),
Copied contents to your clipboard!